[{"data":1,"prerenderedAt":402},["ShallowReactive",2],{"slug-the-future-of-medication-management":3},{"post":4,"relatedPosts":188,"relatedBooks":307},{"id":5,"date":6,"date_gmt":7,"guid":8,"modified":10,"modified_gmt":11,"slug":12,"status":13,"type":14,"link":15,"title":16,"content":18,"excerpt":21,"author":23,"featured_media":24,"comment_status":25,"ping_status":25,"sticky":26,"template":27,"format":28,"meta":29,"categories":30,"tags":34,"project_category":45,"contact_email_category":49,"yst_prominent_words":50,"class_list":61,"better_featured_image":84,"acf":119,"yoast_meta":132,"_links":135},38085,"2025-04-14T07:05:21","2025-04-14T05:05:21",{"rendered":9},"https:\u002F\u002Fmedicalfuturist.com\u002F?post_id=38085&_wpnonce=b5385bd3f9&status=auto-draft&type=post","2025-04-14T07:05:22","2025-04-14T05:05:22","the-future-of-medication-management","publish","post","https:\u002F\u002Fmedicalfuturist.com\u002Fthe-future-of-medication-management",{"rendered":17},"What Is The Technological Future Of Medication Management?",{"rendered":19,"protected":20},"\n\u003Cp>When a patient heads to a healthcare institution and is prescribed medicines, one might expect them to stick to the regimen to improve their health. \u003Cstrong>However, \u003C\u002Fstrong>\u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fblog.cureatr.com\u002F10-strategies-improve-patient-compliance-with-medication\" target=\"_blank\">\u003Cstrong>up to 50% of patients\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong> fail to adhere to their medications as prescribed. \u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp>And around the world, millions are taking medicines. In the U.K., \u003Ca href=\"https:\u002F\u002Fwww.singlecare.com\u002Fblog\u002Fnews\u002Fprescription-drug-statistics\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">over 26% of adults\u003C\u002Fa> take prescription medications. Across the Atlantic ocean, in the U.S., \u003Ca href=\"https:\u002F\u002Fwww.singlecare.com\u002Fblog\u002Fnews\u002Fprescription-drug-statistics\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">some 66% of the adult population\u003C\u002Fa> take prescription drugs. Down in the South Hemisphere, \u003Ca href=\"https:\u002F\u002Fwww.singlecare.com\u002Fblog\u002Fnews\u002Fprescription-drug-statistics\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">around 35% of Australians\u003C\u002Fa> take such medicine on a daily basis. \u003C\u002Fp>\n\n\n\n\u003Cp>With those millions of medicine-taking people comes the inevitable risk of medication errors. In England alone, \u003Ca href=\"https:\u002F\u002Fwww.bmj.com\u002Fcompany\u002Fnewsroom\u002F237-million-medication-errors-made-every-year-in-england\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">researchers found\u003C\u002Fa> that over 237 million medication errors are made every year.\u003C\u002Fp>\n\n\n\n\u003Cp>Ultimately, these add up to the losses incurred both financially and, more importantly, in terms of patient lives. One way to tackle these issues is through medication management. The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) \u003Ca href=\"https:\u002F\u002Fwww.rcn.org.uk\u002Fclinical-topics\u002Fmedicines-management\" target=\"_blank\" rel=\"noreferrer noopener\">defines medicine management as\u003C\u002Fa> “the clinical, cost-effective and safe use of medicines to ensure patients get the maximum benefit from the medicines they need, while at the same time minimising potential harm”.\u003C\u002Fp>\n\n\n\n\u003Cp>However, the methods employed have been stagnant for long and still leave room for improvements, as the numbers show. As healthcare steadily pivots towards digital health, what future do the relevant, novel technologies paint for medication management? Stick with us as this is what we will explore in this article.\u003C\u002Fp>\n\n\n\n\u003Chr class=\"wp-block-separator has-css-opacity\"\u002F>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Medication management, compliance and the empowered patient\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>When it comes to medication management, there are two key sides: the administrative (clinician\u002Fpharmacist) and the patient side. This means that issues can sprout from either end of the spectrum and at every stage of the process from prescribing to dispensing. Considering recent statistics from the U.K. alone, medication errors cost the NHS around £98 million and over 1700 lives every year; and \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.bmj.com\u002Fcompany\u002Fnewsroom\u002F237-million-medication-errors-made-every-year-in-england\u002F\" target=\"_blank\">researchers consider these\u003C\u002Fa> losses as “definitely avoidable”. On a global scale, it’s easy to project the magnitude \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.pillsy.com\u002Farticles\u002Fmedication-adherence-stats\" target=\"_blank\">to be severalfold\u003C\u002Fa>. \u003C\u002Fp>\n\n\n\n\u003Cp>This represents a significant burden that is preventable but that novel technologies in the digital health era can help address. However, the same era is defined by the \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fempowered-patients-in-the-digital-age\u002F\" target=\"_blank\">empowered patient\u003C\u002Fa>. Equipped with digital health tools, having access to their own health data and engaged in online patient communities, the latter are more proactive in managing their care. As such, being tasked to comply with their treatment regimen in the traditional, passive way is an obsolete, if not offensive, approach for the empowered patient.\u003C\u002Fp>\n\n\n\u003Cdiv class=\"wp-block-image\">\n\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"360\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F03\u002FPatient-Doctor-Partnership-768x360.png\" alt=\"empowered patient\" class=\"wp-image-23467\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F03\u002FPatient-Doctor-Partnership-768x360.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F03\u002FPatient-Doctor-Partnership-1536x721.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F03\u002FPatient-Doctor-Partnership-512x240.png 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F03\u002FPatient-Doctor-Partnership.png 1547w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\n\u003C\u002Fdiv>\n\n\n\u003Cp>The patient of the digital health age would rather be more proactive in this process. Engaging them in medication management can thankfully be made possible through digital health approaches and we’ll consider those in the next section.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Medication management in the digital health age\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>With the accessibility of connected devices and remote care, patients and their physicians can share a new dynamic to manage medication. Physicians can prescribe digital health tools to assist patients in managing their medications while also enabling them to monitor adherence. For their part, patients can turn to their doctors remotely in case of concerns. Below are 5 digital health tools that could improve medication management and enable this new dynamic.\u003C\u002Fp>\n\n\n\n\u003Ch4 class=\"wp-block-heading\">\u003Cstrong>1. Smart pill dispensers\u003C\u002Fstrong>\u003C\u002Fh4>\n\n\n\n\u003Cp>Digitally enabled pill dispensers like the \u003Ca href=\"https:\u002F\u002Fjoin.herohealth.com\u002Fqjzo-g\u002Fmanage-my-meds\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">Hero Automatic Medication Dispenser\u003C\u002Fa> and \u003Ca href=\"https:\u002F\u002Fwww.medacube.com\u002Fpages\u002Fhow-it-works\" target=\"_blank\" rel=\"noreferrer noopener\">MedaCube\u003C\u002Fa> deliver audible and visual cues to remind patients to take their medications at the right time and dose. Caregivers and physicians can even track adherence through the companion app.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-embed aligncenter is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\">\u003Cdiv class=\"wp-block-embed__wrapper\">\n\u003Ciframe loading=\"lazy\" title=\"How Hero Works\" width=\"640\" height=\"360\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FaFsxHO4Nltk?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen>\u003C\u002Fiframe>\n\u003C\u002Fdiv>\u003C\u002Ffigure>\n\n\n\n\u003Ch4 class=\"wp-block-heading\">\u003Cstrong>2. Medication reminder apps\u003C\u002Fstrong>\u003C\u002Fh4>\n\n\n\n\u003Cp>For a software-based option, patients can adopt apps like \u003Ca href=\"https:\u002F\u002Fcarezone.com\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">CareZone\u003C\u002Fa> and \u003Ca href=\"https:\u002F\u002Fwww.medisafeapp.com\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">Medisafe\u003C\u002Fa>. These help manage medication regimens and can sync the data with a caregiver or doctor. With this approach, they can be notified when refills are needed or when the patient doesn’t respond to several missed dosage alerts.\u003C\u002Fp>\n\n\n\n\u003Ch4 class=\"wp-block-heading\">\u003Cstrong>3. Digital therapeutics\u003C\u002Fstrong>\u003C\u002Fh4>\n\n\n\n\u003Cp>Other types of software also hold promise in the future of medication management, in particular \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhat-are-digital-therapeutics\u002F\" target=\"_blank\">digital therapeutics\u003C\u002Fa> (DTx). These evidence-based, clinically evaluated software undergo regulatory oversight to ensure their safe and effective use as well as their clinical impact. \u003C\u002Fp>\n\n\n\n\u003Cp>One such DTx product is \u003Ca href=\"https:\u002F\u002Fdtxalliance.org\u002Fproductinsulia\u002F\">Insula\u003C\u002Fa>, a prescription-only software that assists type 2 diabetics to manage their condition. It recommends patients personalised insulin doses as well as acts as a coach in managing their diabetes.\u003C\u002Fp>\n\n\n\u003Cdiv class=\"wp-block-image\">\n\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-768x432.png\" alt=\"\" class=\"wp-image-36065\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-2048x1152.png 2048w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\n\u003C\u002Fdiv>\n\n\n\u003Ch4 class=\"wp-block-heading\">\u003Cstrong>4. Digital pills\u003C\u002Fstrong>\u003C\u002Fh4>\n\n\n\n\u003Cp>The longer-term goal would be to integrate a tracking option in pills themselves, and this is where digital pills come into play. While adoption is still in the early stages, some companies are working on drugs with ingestible electronics for adherence monitoring purposes. Of note, not all drugs will bear the same technology; as digital pills are more appropriate in niche areas where compliance can and should be improved with this tech. For example, patients with severe mental health conditions or the elderly having challenges adhering to their medications can benefit more from digital pills. \u003C\u002Fp>\n\n\n\n\u003Cp>etectRx’s \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedcitynews.com\u002F2019\u002F12\u002Fnew-smart-pill-maker-gains-fda-approval\u002F?rf=1\" target=\"_blank\">FDA-approved digital pill\u003C\u002Fa> gives patients more control over when monitoring starts. It involves a removable lanyard rather than a patch, which patients can remove after taking their medicine. Infármate’s \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fcordis.europa.eu\u002Farticle\u002Fid\u002F418365-pill-tracking-device-promises-targeted-personalised-care\" target=\"_blank\">SIGUEMED\u003C\u002Fa> comes with a trackable blister pack, alerting caregivers when patients take a pill. A companion app informs of the right time to take the pill and alerts contact persons if a mistake has been made.\u003C\u002Fp>\n\n\n\n\u003Ch4 class=\"wp-block-heading\">\u003Cstrong>5. Telemedical platforms\u003C\u002Fstrong>\u003C\u002Fh4>\n\n\n\n\u003Cp>All of these above options can be supplemented by telemedicine consultations. Through these, patients and physicians can routinely hold remote consultations to ensure proper adherence of patients’ to medications. The latter can in turn use such platforms to request advice or raise concerns with their physicians. Given their rising adoption \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fcovid-19-was-needed-for-telemedicine-to-finally-go-mainstream\u002F\" target=\"_blank\">as a result of the pandemic\u003C\u002Fa>, patients and physicians can leverage the availability of such platforms for medication management.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>While these tools hold promise in medication management and enable the digital health patient to become more proactive in their care, they are not definitive solutions. They might not be accessible in all communities due to lack of resources, but their assistance can nevertheless help put a dent in the avoidable burden associated with medication management.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>Written by Dr. Bertalan Meskó & Dr. Pranavsingh Dhunnoo\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cdiv style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\">\u003C\u002Fdiv>\n\n\n\n\u003Ctable style=\"width: 100%; border-collapse: collapse; background-color: #eee; border-top: 4px solid #444;\" cellpadding=\"10px\">\n\u003Ctbody>\n\u003Ctr>\n\u003Ctd style=\"width: 100%;\">\n\u003Cp>\u003Cstrong>At The Medical Futurist, we are building a community for making a bold vision about the future of healthcare reality today.\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Ciframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FFIbMejImnxs\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\">\u003C\u002Fiframe>\n\u003Cp>If you’d like to support this mission, we invite you to \u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">join The Medical Futurist Patreon Community\u003C\u002Fa>. A community of empowered patients, future-oriented healthcare professionals, concerned health policymakers, sensible health tech developers, and enthusiastic medical students. If there were ever a time to join us, it is now. Every contribution, however big or small, powers our research and sustains our future.\u003C\u002Fp>\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">\u003Cstrong style=\"background-color: #e71d3299; color: #000;\">Click here to support The Medical Futurist from as little as $3\u003C\u002Fstrong>\u003C\u002Fa> – it only takes a minute. Thank you.\u003C\u002Fp>\n\u003C\u002Ftd>\n\u003C\u002Ftr>\n\u003C\u002Ftbody>\n\u003C\u002Ftable>\n\u003Cp> \u003C\u002Fp>\n",false,{"rendered":22,"protected":20},"\u003Cp>As healthcare steadily pivots towards digital health, what future do the relevant, novel technologies paint for medication management? \u003C\u002Fp>\n",16,30493,"closed",true,"","standard",{"_acf_changed":20,"footnotes":27},[31,32,33],491,521,490,[35,36,37,38,39,40,41,42,43,44],1385,5035,6255,7341,677,723,759,804,4979,220,[46,47,48],950,951,952,[],[51,52,53,54,55,56,57,58,59,60],1571,5141,1617,1631,1681,1803,1883,2163,3239,4967,[62,14,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83],"post-38085","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-empowered-patients","category-future-medicine","category-future-of-pharma","tag-patients","tag-smart-pill","tag-nhs","tag-digital-therapeutics","tag-drugs","tag-telemedicine","tag-apps","tag-empowered-patients","tag-digital-pill","tag-e-patient","project_category-medical-professionals","project_category-patients","project_category-policy-makers",{"id":24,"alt_text":85,"caption":86,"description":87,"media_type":88,"media_details":89,"post":117,"source_url":118},"Future of Pharmacies","The pharmacy of the future","As patients are the most underused resources of healthcare, pharmacists are the most underused resources of medicine. That needs to change.","image",{"width":90,"height":91,"file":92,"sizes":93,"image_meta":115},1920,1080,"2020\u002F10\u002F210_tmf-01.png",{"medium":94,"large":100,"thumbnail":105,"medium_large":109,"1536x1536":110},{"file":95,"width":96,"height":97,"mime-type":98,"source_url":99},"210_tmf-01-370x208.png","370","208","image\u002Fpng","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F210_tmf-01-370x208.png",{"file":101,"width":102,"height":103,"mime-type":98,"source_url":104},"210_tmf-01-768x432.png","768","432","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F210_tmf-01-768x432.png",{"file":106,"width":107,"height":107,"mime-type":98,"source_url":108},"210_tmf-01-150x150.png","150","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F210_tmf-01-150x150.png",{"file":101,"width":102,"height":103,"mime-type":98,"source_url":104},{"file":111,"width":112,"height":113,"mime-type":98,"source_url":114},"210_tmf-01-1536x864.png","1536","864","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F210_tmf-01-1536x864.png",{"aperture":116,"credit":27,"camera":27,"caption":27,"created_timestamp":116,"copyright":27,"focal_length":116,"iso":116,"shutter_speed":116,"title":27,"orientation":116},"0",30459,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F210_tmf-01.png",{"cta_type":27,"cta_color":27,"subtitle":27,"related_books":120,"related_posts_footer":123,"related_posts":20,"key_takeaways":127},[121,122],24763,24764,[124,125,126],36821,36643,36507,[128,130],{"title":129},"\u003Cp>\u003Ca href=\"https:\u002F\u002Fblog.cureatr.com\u002F10-strategies-improve-patient-compliance-with-medication\" target=\"_blank\" rel=\"noreferrer noopener\">Up to 50% of patients\u003C\u002Fa> fail to adhere to their medications as prescribed. Some technologies could help improve that.\u003C\u002Fp>\n",{"title":131},"\u003Cp>While these tools hold promise in medication management and enable the digital health patient to become more proactive in their care, they are not definitive solutions.\u003C\u002Fp>\n",{"yoast_wpseo_title":133,"yoast_wpseo_metadesc":134,"yoast_wpseo_canonical":15},"What Is The Technological Future Of Medication Management? - The Medical Futurist","Equipped with digital health tools, empowered patients are the key in medicatiion management. The question is if patients want to be empowered.",{"self":136,"collection":142,"about":145,"author":148,"replies":151,"version-history":154,"predecessor-version":158,"wp:featuredmedia":162,"wp:attachment":165,"wp:term":168,"curies":184},[137],{"href":138,"targetHints":139},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F38085",{"allow":140},[141],"GET",[143],{"href":144},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts",[146],{"href":147},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftypes\u002Fpost",[149],{"embeddable":26,"href":150},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F16",[152],{"embeddable":26,"href":153},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=38085",[155],{"count":156,"href":157},18,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F38085\u002Frevisions",[159],{"id":160,"href":161},58675,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F38085\u002Frevisions\u002F58675",[163],{"embeddable":26,"href":164},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F30493",[166],{"href":167},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=38085",[169,172,175,178,181],{"taxonomy":170,"embeddable":26,"href":171},"category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=38085",{"taxonomy":173,"embeddable":26,"href":174},"post_tag","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=38085",{"taxonomy":176,"embeddable":26,"href":177},"project_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=38085",{"taxonomy":179,"embeddable":26,"href":180},"contact_email_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=38085",{"taxonomy":182,"embeddable":26,"href":183},"yst_prominent_words","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=38085",[185],{"name":186,"href":187,"templated":26},"wp","https:\u002F\u002Fapi.w.org\u002F{rel}",[189],{"id":126,"date":190,"date_gmt":191,"guid":192,"modified":194,"modified_gmt":195,"slug":196,"status":13,"type":14,"link":197,"title":198,"content":200,"excerpt":202,"author":23,"featured_media":204,"comment_status":25,"ping_status":25,"sticky":26,"template":27,"format":28,"meta":205,"categories":206,"tags":207,"project_category":216,"contact_email_category":218,"yst_prominent_words":219,"class_list":223,"better_featured_image":234,"acf":254,"yoast_meta":262,"_links":265},"2021-10-12T10:00:00","2021-10-12T08:00:00",{"rendered":193},"https:\u002F\u002Fmedicalfuturist.com\u002F?post_id=36507&_wpnonce=a0cbf10c00&status=auto-draft&type=post","2021-10-12T18:34:11","2021-10-12T16:34:11","big-pharma-part-one","https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-one",{"rendered":199},"Big Pharma, Big Money: Johnson&Johnson, Pfizer, Bayer, Novartis in digital health",{"rendered":201,"protected":20},"\n\u003Cp>In \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Ftech-giants-in-healthcare-2021-summary\" target=\"_blank\">a recent series of articles\u003C\u002Fa>, we explored the latest moves of Tech Giants like \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Famazons-march-into-healthcare-a-2021-update\" target=\"_blank\">Amazon\u003C\u002Fa>, \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fnvidia-in-healthcare-2021\" target=\"_blank\">NVIDIA\u003C\u002Fa> and \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fmicrosoft-in-healthcare-2021\" target=\"_blank\">Microsoft\u003C\u002Fa> in the field of digital health. Analysing these recent developments can give us a better idea regarding where they are focusing the efforts, and how it might shape the future path of healthcare. \u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>But equally, if not more, strong players in this field are pharmaceutical giants, as their resources and influence can significantly shape or alter the course of this path.\u003C\u002Fstrong> As such, we are kickstarting a new series of articles focusing on the digital health efforts of 14 global pharma companies. While those heavyweights are involved in a plethora of healthcare-related projects from vaccine development to clinical trials, we will specifically focus on digital health.\u003C\u002Fp>\n\n\n\n\u003Cp>In the first article to the series, we will explore developments coming from pharma giants Johnson & Johnson, Pfizer, Bayer and Novartis. Let’s take a closer look!\u003C\u002Fp>\n\n\n\n\u003Chr class=\"wp-block-separator\"\u002F>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Johnson & Johnson: consumer-facing\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>While Johnson & Johnson (J&J) has been involved in the healthcare industry for \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.fiercehealthcare.com\u002Ftech\u002Fwhy-johnson-johnson-investing-a-telehealth-startup\" target=\"_blank\">over a century\u003C\u002Fa>, these days the brand is most likely associated with \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.jnj.com\u002Fjohnson-johnson-covid-19-vaccine-authorized-by-u-s-fda-for-emergency-usefirst-single-shot-vaccine-in-fight-against-global-pandemic\" target=\"_blank\">the single-shot COVID-19 vaccine\u003C\u002Fa>. But its pandemic efforts extend beyond the vaccine as well. \u003C\u002Fp>\n\n\n\n\u003Cp>In early 2020, the company \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.prnewswire.com\u002Fnews-releases\u002Fprisma-health-collaborates-with-ethicon-inc-part-of-the-johnson--johnson-medical-devices-companies-to-manufacture-and-distribute-the-vesper-ventilator-expansion-splitter-device-that-is-authorized-for-emergency-use-only-during-301035945.html\" target=\"_blank\">partnered with Prisma Health\u003C\u002Fa> for the manufacturing and distribution of the VESper Ventilator Expansion Splitter, a ventilator expansion device. A single ventilator fitted with it can provide ventilatory support for two rescuable patients until individual ventilators are available.\u003C\u002Fp>\n\n\n\n\u003Cp>J&J also explored other digital health technologies that proved to be valuable during the crisis. It \u003Ca href=\"https:\u002F\u002Fwww.jnj.com\u002Finnovation\u002F4-ways-johnson-johnson-advanced-healthcare-amid-the-pandemic\" target=\"_blank\" rel=\"noreferrer noopener\">collaborated with Koa Health\u003C\u002Fa> to research the use of digital cognitive behavioral therapy for treatment-resistant major depressive disorder. \u003C\u002Fp>\n\n\n\n\u003Cp>Another pandemic-ready technology that the pharmaceutical giant showed interest in is telemedicine. In Q3 2020, the company \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.fiercehealthcare.com\u002Ftech\u002Fwhy-johnson-johnson-investing-a-telehealth-startup\" target=\"_blank\">announced that it is investing\u003C\u002Fa> in direct-to-consumer telehealth company Thirty Madison. The latter focuses on conditions like hair loss and acid reflux, whose treatments are sold by J&J itself.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"260\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Fjohnson-and-johnson-covid-768x260.jpg\" alt=\"\" class=\"wp-image-36509\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Fjohnson-and-johnson-covid-768x260.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Fjohnson-and-johnson-covid.jpg 1534w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003Cfigcaption>Source: https:\u002F\u002Fwww.jnj.com\u002F\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Still on the topic of consumer-oriented digital health tools, the pharma giant \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.jnj.com\u002Fjohnson-johnson-launches-heartline-the-first-of-its-kind-virtual-study-designed-to-explore-if-a-new-iphone-app-and-apple-watch-can-help-reduce-the-risk-of-stroke\" target=\"_blank\">announced its partnership with Apple\u003C\u002Fa> in February 2020. The collaboration involves a study using the Apple Watch to determine whether the device can detect atrial fibrillation earlier so as to reduce the risk of developing stroke and improve health outcomes. Paul Burton, J&J’s vice president of medical affairs, \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.cnbc.com\u002F2020\u002F02\u002F25\u002Fapple-johnson-johnson-heart-study-is-a-big-deal-for-digital-health.html\" target=\"_blank\">even told CNBC\u003C\u002Fa> that this study “\u003Cem>represents the largest randomized trial in the history of cardiovascular disease\u003C\u002Fem>.”\u003C\u002Fp>\n\n\n\n\u003Cp>J&J also made moves in the clinical sphere with its surgical robotic platform \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.massdevice.com\u002Fbreaking-johnson-johnson-finally-unveils-its-new-robot-assisted-surgery-system\u002F\" target=\"_blank\">announced last November\u003C\u002Fa>. Designed with six arms and integrated into the operating table, this new system aims to provide better control and flexibility to surgeons.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Pfizer: eyeing digital therapeutics\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Pfizer is another pharma giant whose name is closely attached to a COVID-19 vaccine; but like its competitor J&J, it has also been venturing into the field of digital health. More specifically, it seems to have grown some interests in the emerging \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhat-are-digital-therapeutics\" target=\"_blank\">digital therapeutics (DTx) solutions\u003C\u002Fa>. In mid-2020, the company, in collaboration with SidekickHealth, \u003Ca rel=\"noreferrer noopener\" href=\"http:\u002F\u002Fwww.pharmatimes.com\u002Fnews\u002Fpfizer_links_with_sidekickhealth_for_digital_health_solution_1343312\" target=\"_blank\">launched a new digital therapeutics platform\u003C\u002Fa>. It aims to help patients with ailments like inflammatory bowel disease and arthritis gain more control over managing their condition and improve their wellbeing.\u003C\u002Fp>\n\n\n\n\u003Cp>Pfizer announced another similar collaboration in April 2021 \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Ffinance.yahoo.com\u002Fnews\u002Fpfizer-collaborates-doctoroncall-improve-health-033200173.html\" target=\"_blank\">with DoctorOnCall\u003C\u002Fa> in Malaysia. For its part, this DTx platform will focus on the three therapeutic areas of smoking cessation, vaccination and cardiovascular health.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-768x432.png\" alt=\"\" class=\"wp-image-36065\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01-2048x1152.png 2048w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Ftmf_article_290-01.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>In late 2020, the pharma giant, along with some other companies, \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fhitconsultant.net\u002F2020\u002F12\u002F29\u002Famazon-astrazeneca-pfizer-innovation-lab-israel\u002F#.YVGaKLgzaUk\" target=\"_blank\">was selected by the Israel Innovation Authority\u003C\u002Fa> to work on an innovation lab project in the fields of digital health and computational biology. The lab aims to support startups working on A.I.-based tools for personalised treatments.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Bayer: partnerships and investments\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>German pharma company Bayer is no stranger to digital health. In 2018, it partnered with appliedVR and Samsung Health to \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fdigital-pain-reduction-kit-against-chronic-pain\u002F\" target=\"_blank\">develop digital pain reduction kits\u003C\u002Fa> using virtual reality technology. Its digital health endeavours have not waned in following years.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"712\" height=\"401\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Fbayer-big-pharma.jpg\" alt=\"\" class=\"wp-image-36511\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Fbayer-big-pharma.jpg 712w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Fbayer-big-pharma-370x208.jpg 370w\" sizes=\"auto, (max-width: 712px) 100vw, 712px\" \u002F>\u003Cfigcaption>Source: https:\u002F\u002Fwww.mobihealthnews.com\u002F\u003C\u002Ffigcaption>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>In early 2020, Bayer \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Femea\u002Fexscientia-lands-multi-million-euro-deal-bayer\" target=\"_blank\" rel=\"noreferrer noopener\">entered a three-year partnership\u003C\u002Fa> with British biotech firm Exscientia. The focus will be on using artificial intelligence in drug discovery in the fields of cardiology and oncology. Later that year, the pharma giant \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fbayer-looks-digital-partnerships-expand-efforts-cardiometabolic-care-oncology-and-womens-health\" target=\"_blank\" rel=\"noreferrer noopener\">launched its G4A Digital Health Partnership Program\u003C\u002Fa>. Through the latter, it will support both early-stage and experienced companies to develop digital health tools.\u003C\u002Fp>\n\n\n\n\u003Cp>Prior to this initiative, Bayer also invested in other digital health startups. For instance, in August 2020, they \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fbayers-equity-investment-development-commitments-bring-nearly-100m-one-drop\" target=\"_blank\">invested in One Drop\u003C\u002Fa>, the maker of a data-driven blood glucose monitor system. With this new round of funding, this startup will expand its expertise in other areas like cardiology, oncology and women’s health. \u003C\u002Fp>\n\n\n\n\u003Cp>In June 2021, the German company \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedcitynews.com\u002F2021\u002F06\u002Fbayers-investment-arm-leads-digital-health-startups-90m-round\u002F\" target=\"_blank\">invested in yet another digital health startup\u003C\u002Fa>: Ada Health. The latter is known for \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fthe-big-symptom-checker-review\u002F\" target=\"_blank\">its A.I.-based symptom checker\u003C\u002Fa>. Through this investment, the two companies also plan a broader strategic partnership. \u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Novartis: juggling between projects and failures\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>“Embracing digital and data is a top priority for Novartis,” the company’s chief medical officer John Tsai \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Femea\u002Fhow-novartis-embracing-digital-and-data-revolution\">once said\u003C\u002Fa>. The Swiss pharma giant has been walking that talk in recent years; even after its ill-fated partnership with Google to develop blood glucose level-sensing contact lenses that \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fthe-future-of-diabetes-management-8-reasons-why-we-face-extraordinary-times\">didn’t amount to a viable product\u003C\u002Fa>.\u003C\u002Fp>\n\n\n\n\u003Cp>In late 2019, it teamed up with another Big Tech company, Microsoft, \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fnorth-america\u002Fnovartis-taps-microsoft-new-ai-initiative-drug-discovery-development\">on an initiative\u003C\u002Fa> to use A.I. for drug discovery and development. More recently, the Swiss pharma giant partnered with a number of digital health startups. Last November, they \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fnovartis-teams-smartpatient-new-tool-patients-wet-macular-degeneration\">teamed up with smartpatient and the MyTherapy app\u003C\u002Fa> for a new feature to provide personalised educational material for wet macular degeneration patients and their caregivers.  \u003C\u002Fp>\n\n\n\n\u003Cp>In April, it \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fkaiku-health-joins-forces-novartis-melanoma-monitoring-and-support\">partnered with Kaiku Health\u003C\u002Fa> on a tool to assist in the remote monitoring and support network of melanoma patients. The following month, in May, it announced \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Femea\u002Fada-health-partners-novartis-work-diagnosis-immunological-diseases\">a collaboration with Ada Health\u003C\u002Fa> to help improve the diagnosis for patients with immunological diseases and rare conditions.\u003C\u002Fp>\n\n\n\n\u003Cp>Novartis not only partnered with startups but also acquired one. In 2020, they \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fnovartis-acquires-digital-therapeutic-using-video-games-3d-glasses-treat-lazy-eye\">acquired Amblyotech\u003C\u002Fa>, which develops a solution to treat amblyopia, or “lazy eye”, by combining a gaming software and 3D glasses. \u003C\u002Fp>\n\n\n\n\u003Cp>Like Pfizer, Novartis also expressed interest in DTx, but not with such a promising outlook. The pharma giant \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fnovartis-trial-shows-no-benefits-pears-schizophrenia-app-ceo-cites-trial-irregularities\">published results of its clinical trial\u003C\u002Fa> with Pear Therapeutics’ new digital therapeutic for schizophrenia in January. It didn’t find benefits from the app but Pear Therapeutics said there were “methodological issues” that were omitted in Novartis’s publication.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"403\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002FPear-Therapeutics-DTx-768x403.jpg\" alt=\"\" class=\"wp-image-36513\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002FPear-Therapeutics-DTx-768x403.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002FPear-Therapeutics-DTx.jpg 1200w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003Cfigcaption>Source: https:\u002F\u002Fwww.mobihealthnews.com\u002F\u003C\u002Ffigcaption>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>From this list, we can see that the pharma companies whose moves we’ve contemplated seem to have some interest in remote healthcare solutions and DTx. They are also actively partnering with startups and tech giants so as to maximise their chances of staying relevant in the ever-evolving digital health world. In the next articles in this series, we will analyse how, and if, the approach of other pharma giants differ. Be sure to keep an eye out for those!\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>Written by Dr. Bertalan Meskó & Dr. Pranavsingh Dhunnoo\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Ctable style=\"width: 100%; border-collapse: collapse; background-color: #eee; border-top: 4px solid #444;\" cellpadding=\"10px\">\n\u003Ctbody>\n\u003Ctr>\n\u003Ctd style=\"width: 100%;\">\n\u003Cp>\u003Cstrong>At The Medical Futurist, we are building a community for making a bold vision about the future of healthcare reality today.\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Ciframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FFIbMejImnxs\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\">\u003C\u002Fiframe>\n\u003Cp>If you’d like to support this mission, we invite you to \u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">join The Medical Futurist Patreon Community\u003C\u002Fa>. A community of empowered patients, future-oriented healthcare professionals, concerned health policymakers, sensible health tech developers, and enthusiastic medical students. If there were ever a time to join us, it is now. Every contribution, however big or small, powers our research and sustains our future.\u003C\u002Fp>\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">\u003Cstrong style=\"background-color: #e71d3299; color: #000;\">Click here to support The Medical Futurist from as little as $3\u003C\u002Fstrong>\u003C\u002Fa> – it only takes a minute. Thank you.\u003C\u002Fp>\n\u003C\u002Ftd>\n\u003C\u002Ftr>\n\u003C\u002Ftbody>\n\u003C\u002Ftable>\n\u003Cp> \u003C\u002Fp>\n\n\n\n\u003Cdiv style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\">\u003C\u002Fdiv>\n",{"rendered":203,"protected":20},"\u003Cp>In a recent series of articles, we explored the latest moves of Tech Giants like Amazon, NVIDIA and Microsoft in the field of digital health. […]\u003C\u002Fp>\n",36565,{"_acf_changed":20,"footnotes":27},[32,33],[208,209,210,211,212,213,214,215],207,336,356,6365,7001,7385,7387,7389,[217],947,[],[57,58,220,51,221,222,53,55],4363,1609,1611,[224,14,63,64,65,66,67,69,70,225,226,227,228,229,230,231,232,233],"post-36507","tag-digital-health","tag-novartis","tag-pharma-2","tag-pfizer","tag-jj","tag-big-pharma","tag-johnsonjohnson","tag-bayer","project_category-company",{"id":204,"alt_text":27,"caption":27,"description":235,"media_type":88,"media_details":236,"post":126,"source_url":253}," Big Pharma, Big Money: J&J, Pfizer, Bayer, Novartis in digital health",{"width":90,"height":91,"file":237,"sizes":238,"image_meta":252},"2021\u002F10\u002Ftmf_article_295-01.png",{"medium":239,"large":242,"thumbnail":245,"medium_large":248,"1536x1536":249},{"file":240,"width":96,"height":97,"mime-type":98,"source_url":241},"tmf_article_295-01-370x208.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Ftmf_article_295-01-370x208.png",{"file":243,"width":102,"height":103,"mime-type":98,"source_url":244},"tmf_article_295-01-768x432.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Ftmf_article_295-01-768x432.png",{"file":246,"width":107,"height":107,"mime-type":98,"source_url":247},"tmf_article_295-01-150x150.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Ftmf_article_295-01-150x150.png",{"file":243,"width":102,"height":103,"mime-type":98,"source_url":244},{"file":250,"width":112,"height":113,"mime-type":98,"source_url":251},"tmf_article_295-01-1536x864.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Ftmf_article_295-01-1536x864.png",{"aperture":116,"credit":27,"camera":27,"caption":27,"created_timestamp":116,"copyright":27,"focal_length":116,"iso":116,"shutter_speed":116,"title":27,"orientation":116},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F10\u002Ftmf_article_295-01.png",{"cta_type":255,"cta_color":27,"subtitle":27,"related_books":256,"related_posts_footer":258,"related_posts":20},"subscribe",[122,257],31417,[259,260,261],15585,17427,35983,{"yoast_wpseo_title":263,"yoast_wpseo_metadesc":264,"yoast_wpseo_canonical":197},"Big Pharma, Big Money: Johnson&Johnson, Pfizer, Bayer, Novartis in digital health - The Medical Futurist","Big pharma: a new series of articles by The Medical Futurist, focusing on the digital health efforts of the biggest pharma companies around the globe",{"self":266,"collection":271,"about":273,"author":275,"replies":277,"version-history":280,"predecessor-version":284,"wp:featuredmedia":288,"wp:attachment":291,"wp:term":294,"curies":305},[267],{"href":268,"targetHints":269},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36507",{"allow":270},[141],[272],{"href":144},[274],{"href":147},[276],{"embeddable":26,"href":150},[278],{"embeddable":26,"href":279},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=36507",[281],{"count":282,"href":283},15,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36507\u002Frevisions",[285],{"id":286,"href":287},36561,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36507\u002Frevisions\u002F36561",[289],{"embeddable":26,"href":290},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F36565",[292],{"href":293},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=36507",[295,297,299,301,303],{"taxonomy":170,"embeddable":26,"href":296},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=36507",{"taxonomy":173,"embeddable":26,"href":298},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=36507",{"taxonomy":176,"embeddable":26,"href":300},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=36507",{"taxonomy":179,"embeddable":26,"href":302},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=36507",{"taxonomy":182,"embeddable":26,"href":304},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=36507",[306],{"name":186,"href":187,"templated":26},[308],{"id":122,"date":309,"date_gmt":310,"guid":311,"modified":313,"modified_gmt":314,"slug":315,"status":13,"type":316,"link":317,"title":318,"content":320,"excerpt":322,"author":324,"featured_media":325,"comment_status":25,"ping_status":25,"template":27,"yst_prominent_words":326,"class_list":329,"better_featured_image":332,"acf":350,"yoast_meta":370,"_links":373},"2019-09-06T22:00:04","2019-09-06T20:00:04",{"rendered":312},"https:\u002F\u002Fapi.medicalfuturist.com\u002F?post_type=book&p=24764","2023-03-12T18:14:56","2023-03-12T17:14:56","technologies-shaping-the-future-of-pharma","book","https:\u002F\u002Fapi.medicalfuturist.com\u002Fbooks\u002Ftechnologies-shaping-the-future-of-pharma\u002F",{"rendered":319},"How Technologies are Shaping the Future of Pharma",{"rendered":321,"protected":20},"\n\u003Cp>We designed this e-book to serve as a collection of relevant examples, best practices and exciting ideas that can help any pharmaceutical company prepare for change. Many pharma companies have been trying to hop on the “digital train”. \u003Ca href=\"https:\u002F\u002Fleanpub.com\u002Fthefutureofpharma\" target=\"_blank\" rel=\"noreferrer noopener\">This e-book\u003C\u002Fa> was meant to prove that instead of a train of innovation, stakeholders should think in terms of spaceships and while there is still time to embrace digital health and patient empowerment, those that do it faster will get exponentially ahead of their competitors.\u003C\u002Fp>\n",{"rendered":323,"protected":20},"\u003Cp>We designed this e-book to serve as a collection of relevant examples, best practices and exciting ideas that can help any pharmaceutical company prepare for […]\u003C\u002Fp>\n",10,49977,[55,327,328],2349,4977,[330,316,331,64,66,67],"post-24764","type-book",{"id":325,"alt_text":27,"caption":27,"description":27,"media_type":88,"media_details":333,"post":122,"source_url":349},{"width":334,"height":335,"file":336,"filesize":337,"sizes":338,"image_meta":348},320,415,"2019\u002F09\u002Ffuture-of-pharma.png",23355,{"medium":339,"thumbnail":344},{"file":340,"width":341,"height":97,"mime-type":98,"filesize":342,"source_url":343},"future-of-pharma-320x208.png","320","49756","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F09\u002Ffuture-of-pharma-320x208.png",{"file":345,"width":107,"height":107,"mime-type":98,"filesize":346,"source_url":347},"future-of-pharma-150x150.png","21008","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F09\u002Ffuture-of-pharma-150x150.png",{"aperture":116,"credit":27,"camera":27,"caption":27,"created_timestamp":116,"copyright":27,"focal_length":116,"iso":116,"shutter_speed":116,"title":27,"orientation":116},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F09\u002Ffuture-of-pharma.png",{"leanpub_url":351,"buy_button_text":352,"preview":353},"https:\u002F\u002Fleanpub.com\u002Fthefutureofpharma?utm_source=books&utm_medium=referral","Get it on Leanpub",[354,356,358,360,362,364,366,368],{"image":355},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F09\u002F1114_pharma_ebook_2022-cover-copy.png",{"image":357},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F09\u002FTechnologies-Shaping-The-Future-of-Pharma-UPDATED-03.png",{"image":359},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F09\u002FTechnologies-Shaping-The-Future-of-Pharma-UPDATED-04.png",{"image":361},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F09\u002FTechnologies-Shaping-The-Future-of-Pharma-UPDATED-05.png",{"image":363},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F09\u002FTechnologies-Shaping-The-Future-of-Pharma-UPDATED-06.png",{"image":365},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F09\u002FTechnologies-Shaping-The-Future-of-Pharma-UPDATED-07.png",{"image":367},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F09\u002FTechnologies-Shaping-The-Future-of-Pharma-UPDATED-08.png",{"image":369},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F09\u002FTechnologies-Shaping-The-Future-of-Pharma-UPDATED-09.png",{"yoast_wpseo_title":371,"yoast_wpseo_metadesc":372,"yoast_wpseo_canonical":317},"How Technologies are Shaping the Future of Pharma - The Medical Futurist","This e-book serves as a collection of relevant examples, best practices and exciting ideas that can help pharmaceuticcal companies prepare for change.",{"self":374,"collection":379,"about":382,"author":385,"replies":388,"wp:featuredmedia":391,"wp:attachment":394,"wp:term":397,"curies":400},[375],{"href":376,"targetHints":377},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fbook\u002F24764",{"allow":378},[141],[380],{"href":381},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fbook",[383],{"href":384},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftypes\u002Fbook",[386],{"embeddable":26,"href":387},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F10",[389],{"embeddable":26,"href":390},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=24764",[392],{"embeddable":26,"href":393},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F49977",[395],{"href":396},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=24764",[398],{"taxonomy":182,"embeddable":26,"href":399},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=24764",[401],{"name":186,"href":187,"templated":26},1787036508678]